First Trust Investment Solutions »

Nektar Therapeutics shares owned by First Trust Investment Solutions

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by First Trust Investment Solutions from 13F filings

Historical chart of First Trust Investment Solutions investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by First Trust Investment Solutions consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by First Trust Investment Solutions

Quarter filed Position value Share count Share price at filing
2024-03-31 $19k 20k 0.93

More positions owned by First Trust Investment Solutions

Meta Platforms Cl A (META)
Apple (AAPL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Bristol Myers Squibb (BMY)
Select Sector Spdr Tr Technology (XLK)
Raytheon Technologies Corp (RTX)
Nextera Energy (NEE)
CVS Caremark Corporation (CVS)
Oracle Corporation (ORCL)
Citigroup Com New (C)
Discover Financial Services (DFS)
Comcast Corp Cl A (CMCSA)
Cisco Systems (CSCO)
Sherwin-Williams Company (SHW)
Eastman Chemical Company (EMN)

View all positions for First Trust Investment Solutions

Top funds holding Nektar Therapeutics

Deep Track Capital
BlackRock
Vanguard Group
Samlyn Capital
Eventide Asset Management
Citadel Advisors
PRIMECAP Management Company
Acadian Asset Management
Millennium Management
Geode Capital Management
Nantahala Capital Management
TCG Crossover Management
Renaissance Technologies
State Street Corporation
Jacobs Levy Equity Management

View all funds holding Nektar Therapeutics